Drug Trials Snapshot: VANRAFIA
VANRAFIA is an endothelin type A receptor antagonist that is indicated to reduce proteinuria in adults with primary immunoglobulin A…
FDA and Kratom
Kratom is not lawfully marketed in the U.S. as a drug product, a dietary supplement, or a food additive in…
Hydroxie, LLC – 709661 – 06/25/2025
Unapproved New Drug/Human Food/Adulterated
Royal Diamond Imports, Inc. – 709540 – 06/25/2025
Unapproved New Drug/Misbranded
7Tabz Retail, LLC – 709546 – 06/25/2025
Unapproved New Drugs
Covalent Medical – 695839 – 07/09/2025
Unapproved New Drugs/Misbranded
Scope Health Inc – 695085 – 07/09/2025
Unapproved New Drugs/Misbranded
Thea Pharma, Inc. – 712416 – 07/09/2025
Unapproved New Drugs/Misbranded
Revitalize Energy, Inc. – 712417 – 07/09/2025
Unapproved New Drugs/Misbranded
EyeTech One, LLC – 712438 – 07/09/2025
Unapproved New Drugs/Misbranded